A study on the effect of diabetes drugs (SGLT2 inhibitor and DPP4 inhibitor) for nonalcoholic fatty liver disease
Not Applicable
- Conditions
- nonalcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000027304
- Lead Sponsor
- Department of Hepatology, Shimane University Hospital
- Brief Summary
Administration of SGLT2 inhibitors or DPP4 inhibitors significantly reduced ALT levels.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
Cases with severe heart, liver and kidney disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of change of ALT value after 12 weeks from the start of administration
- Secondary Outcome Measures
Name Time Method